C Sardu1,2, M Santamaria1, M R Rizzo2, M Barbieri2, M di Marino1, G Paolisso2, G Santulli3, R Marfella2. 1. Department of Arrhythmias and Electrophysiology, 'John Paul II' Research and Care Foundation, Campobasso, Italy. 2. Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy. 3. Columbia University Medical Center, New York, NY, USA.
Abstract
AIM: Telemonitoring (TM) is a safe and efficient monitoring system for internal cardioverter defibrillator device (ICD) recipients. TM has been used to track info on the clinical status of heart failure patients treated by ICD and/or cardiac resynchronisation therapy defibrillator (CRT-D). The aim of this study was to investigate the impact of TM on clinical outcomes in a population of CRT-D patients with heart failure. METHODS: In a multicentre, randomised study, patients with chronic heart failure, New York Heart Association (NYHA) functional class II or III, left bundle branch block, severe left ventricle ejection fraction reduction (LVEF < 35%) have been identified and screened. RESULTS:One hundred and ninety-one patients have been randomised to receive either a CRT-D with TM or a CRT-D with traditional ambulatory monitoring (control group) and completed the 12-month study follow-up. Primary endpoints were all cause death, cardiac death and hospital admission for heart failure. Secondary endpoints were atrial fibrillation, sustained episodes, non-sustained andself terminated ventricular tachyarrhythmia, sustained ventricular tachycardia, and ventricular fibrillation, ICD shocks and percentage of CRT-D responder patients. Univariate analysis identified the following factors predicting hospitalisation: TM, age, chronic kidney disease, hypercholesterolaemia, LVEF and NYHA class. At multivariate analysis, TM was the only factor predicting heart failure hospitalisation (hazard ratio 0.6, 0.42-0.79, 95% CI, p = 0.002), without affecting overall mortality and cardiac deaths events. CONCLUSIONS: Taken together, our data indicate the importance of TM in predicting heart failure hospitalisation in patients treated with CRT-D.
RCT Entities:
AIM: Telemonitoring (TM) is a safe and efficient monitoring system for internal cardioverter defibrillator device (ICD) recipients. TM has been used to track info on the clinical status of heart failurepatients treated by ICD and/or cardiac resynchronisation therapy defibrillator (CRT-D). The aim of this study was to investigate the impact of TM on clinical outcomes in a population of CRT-D patients with heart failure. METHODS: In a multicentre, randomised study, patients with chronic heart failure, New York Heart Association (NYHA) functional class II or III, left bundle branch block, severe left ventricle ejection fraction reduction (LVEF < 35%) have been identified and screened. RESULTS: One hundred and ninety-one patients have been randomised to receive either a CRT-D with TM or a CRT-D with traditional ambulatory monitoring (control group) and completed the 12-month study follow-up. Primary endpoints were all cause death, cardiac death and hospital admission for heart failure. Secondary endpoints were atrial fibrillation, sustained episodes, non-sustained and self terminated ventricular tachyarrhythmia, sustained ventricular tachycardia, and ventricular fibrillation, ICD shocks and percentage of CRT-D responder patients. Univariate analysis identified the following factors predicting hospitalisation: TM, age, chronic kidney disease, hypercholesterolaemia, LVEF and NYHA class. At multivariate analysis, TM was the only factor predicting heart failure hospitalisation (hazard ratio 0.6, 0.42-0.79, 95% CI, p = 0.002), without affecting overall mortality and cardiac deaths events. CONCLUSIONS: Taken together, our data indicate the importance of TM in predicting heart failure hospitalisation in patients treated with CRT-D.
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: Circulation Date: 2014-03-28 Impact factor: 29.690
Authors: Arthur J Moss; Henry Greenberg; Robert B Case; Wojciech Zareba; W Jackson Hall; Mary W Brown; James P Daubert; Scott McNitt; Mark L Andrews; Adam D Elkin Journal: Circulation Date: 2004-12-06 Impact factor: 29.690
Authors: G A Lamas; K Lee; M Sweeney; A Leon; R Yee; K Ellenbogen; S Greer; D Wilber; R Silverman; R Marinchak; R Bernstein; R S Mittleman; E H Lieberman; C Sullivan; L Zorn; G Flaker; E Schron; E J Orav; L Goldman Journal: Am Heart J Date: 2000-10 Impact factor: 4.749
Authors: S L D'Ascia; C D'Ascia; V Marino; A Lombardi; R Santulli; M Chiariello; G Santulli Journal: Int J Clin Pract Date: 2011-11 Impact factor: 2.503
Authors: Inder S Anand; Peter Carson; Elizabeth Galle; Rui Song; John Boehmer; Jalal K Ghali; Brian Jaski; JoAnn Lindenfeld; Christopher O'Connor; Jonathan S Steinberg; Jill Leigh; Patrick Yong; Michael R Kosorok; Arthur M Feldman; David DeMets; Michael R Bristow Journal: Circulation Date: 2009-02-09 Impact factor: 29.690
Authors: Ahmad Al-Abdouh; Mohammed Mhanna; Mohammad As Sayaideh; Mahmoud Barbarawi; Waiel Abusnina; Ahmad Jabri; Hossam Alzu'bi; Anan Abu Rmilah; Ikram-Ul Haq; Ashish Kumar; Taha Ahmed; Erin D Michos; Gurukripa N Kowlgi; Abhishek Deshmukh Journal: Curr Heart Fail Rep Date: 2022-10-07